Dongguan Longshi shoe material Co., Ltd – Trademark Portfolio
Entity Type: 99
Dongguan Longshi shoe material Co., Ltd has 4 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 4 are successfully registered — a 100% registration rate. The portfolio includes marks such as ZEPOHCK. Filings span 4 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 10 (Medical Apparatus). This trademark owner is based in Dongguan.
Room 302, Building 2, No.70
Dongguan 523943 , CN
Showing of trademarks Trademarks
Trademark Classifications
Dongguan Longshi shoe material Co., Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Dongguan Longshi shoe material Co., Ltd have?
Dongguan Longshi shoe material Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Dongguan Longshi shoe material Co., Ltd file in?
Dongguan Longshi shoe material Co., Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods). Class 25 covers clothing, footwear, headgear.
What are Dongguan Longshi shoe material Co., Ltd's most well-known trademarks?
Dongguan Longshi shoe material Co., Ltd's registered trademark portfolio includes well-known marks such as ZEPOHCK. These are among 4 currently registered trademarks in the portfolio.
What is Dongguan Longshi shoe material Co., Ltd's trademark registration success rate?
Dongguan Longshi shoe material Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.